Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (3) , 474-481
- https://doi.org/10.1016/j.jhep.2004.05.012
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Explanatory and pragmatic attitudes in therapeutical trialsPublished by Elsevier ,2004
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Sponsorship, Authorship, and AccountabilityAnnals of Internal Medicine, 2001
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsAnnals of Internal Medicine, 2001
- Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertensionJournal of Hepatology, 2000
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Reporting results of cancer treatmentCancer, 1981